Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: can we stop the bleeding?

ASAIO J. 2013 Jul-Aug;59(4):450-1. doi: 10.1097/MAT.0b013e318295232d.

Abstract

Left ventricular support devices (LVADs) are associated with a propensity toward gastrointestinal bleeding. A postulated mechanism is related to gastrointestinal arteriovenous malformations secondary to nonpulsatile flow. We describe a case of LVAD-related, gastrointestinal bleeding successfully treated with a combination of subcutaneous and intramuscular depot formulations of octreotide.

Publication types

  • Case Reports

MeSH terms

  • Gastrointestinal Agents / therapeutic use*
  • Gastrointestinal Hemorrhage / drug therapy*
  • Gastrointestinal Hemorrhage / etiology
  • Heart Failure / surgery
  • Heart-Assist Devices / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Octreotide / therapeutic use*

Substances

  • Gastrointestinal Agents
  • Octreotide